Judge Rules in Favor of Teva, Against Opiant and Emergent Biosolutions

A judge ruled in favor of Teva Pharmaceuticals Industries Ltd., and against Opiant Pharmaceuticals Inc. and Emergent Biosolutions Inc., in a patent dispute related to Narcan spray, Bloomberg Law reported Friday.

–Opiant shares fell 35% to $7.57 after hours, while Emergent was down 14% to $75. Teva rose 1.6% to $13.05

https://www.morningstar.com/news/dow-jones/202006058700/judge-rules-in-favor-of-teva-against-opiant-and-emergent-biosolutions-bloomberg-law